RAPEZZI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 5.826
EU - Europa 2.888
AS - Asia 1.082
SA - Sud America 11
AF - Africa 9
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.823
Nazione #
US - Stati Uniti d'America 5.820
PL - Polonia 1.132
IT - Italia 1.106
CN - Cina 390
SG - Singapore 340
GB - Regno Unito 204
ID - Indonesia 128
FI - Finlandia 111
DE - Germania 97
VN - Vietnam 93
UA - Ucraina 89
SE - Svezia 76
TR - Turchia 52
HK - Hong Kong 26
JP - Giappone 22
IN - India 17
CH - Svizzera 12
FR - Francia 12
IE - Irlanda 8
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
CA - Canada 5
EG - Egitto 5
GR - Grecia 5
IR - Iran 5
TW - Taiwan 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
RO - Romania 4
CL - Cile 3
CO - Colombia 3
BE - Belgio 2
BG - Bulgaria 2
DK - Danimarca 2
ES - Italia 2
EU - Europa 2
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
ZM - Zambia 1
Totale 9.823
Città #
Warsaw 1.128
Fairfield 1.009
Woodbridge 540
Houston 440
Ashburn 434
Wilmington 413
Seattle 362
Cambridge 338
Chandler 335
Princeton 308
Beijing 194
Singapore 193
Ann Arbor 187
San Diego 136
Jakarta 127
Jacksonville 103
Milan 103
Rome 98
Dong Ket 93
Helsinki 86
London 79
Shanghai 72
New York 70
Falls Church 51
Ferrara 44
Bologna 35
Chicago 32
Florence 32
Izmir 32
Redwood City 31
Bremen 30
Naples 30
Nanjing 29
Palermo 29
Norwalk 26
Boardman 23
Hong Kong 22
Mountain View 20
Kilburn 16
Redmond 16
Bari 15
Hounslow 14
Brescia 12
San Mateo 11
Turin 11
Jinan 10
Munich 10
Tianjin 10
Nanchang 9
Osaka 9
Salerno 9
Changsha 8
Chiswick 8
Dearborn 8
Trieste 8
Genoa 7
Lanzhou 7
Lappeenranta 7
Leawood 7
Livorno 7
Padova 7
Pisa 7
Verona 7
Castelnuovo Rangone 6
Des Moines 6
Haikou 6
Los Angeles 6
Marigliano 6
Messina 6
New Delhi 6
Parma 6
Reggio Emilia 6
Shenyang 6
Washington 6
Acton 5
Addison 5
Catania 5
Deiva Marina 5
Dublin 5
Hebei 5
Islington 5
Montecchio Maggiore 5
Ningbo 5
Ostuni 5
Piacenza 5
Santa Maria Di Sala 5
Viterbo 5
Ancona 4
Athens 4
Binetto 4
Brixen 4
Brno 4
Cagliari 4
Central District 4
Formigine 4
Frankfurt am Main 4
Guangzhou 4
Hangzhou 4
L'aquila 4
Modena 4
Totale 7.737
Nome #
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 523
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 303
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 277
Heart failure with preserved ejection fraction: uncertainties and dilemmas 147
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 130
Gender-related risk of myocardial involvement in systemic amyloidosis 129
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 124
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 122
Treatment of cardiac transthyretin amyloidosis: An update 114
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 112
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 107
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 103
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 100
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 98
The Mediterranean diet: a cultural journey 97
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 95
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 94
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 94
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 92
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 91
null 89
The residual risk of cerebral embolism after carotid stenting: the complex interplay between stent coverage and aortic arch atherosclerosis. 84
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 81
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 80
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 78
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 76
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 73
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 73
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 72
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 72
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 71
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 71
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 69
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 66
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 65
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 65
Left atrial structure and function in cardiac amyloidosis 63
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 62
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 61
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 61
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 59
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 56
Heart rate modulation in stable coronary artery disease without clinical heart failure: What we have already learned from SIGNIFY? 55
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 55
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 55
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 55
The complex interplay between systolic and diastolic function at rest and during exercise in heart failure: the case of cardiac amyloidosis 54
A targeted proteomics approach to amyloidosis typing 52
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 52
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 52
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 51
Inverted U-Shaped Relation between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy 51
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 51
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 50
Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy 50
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 50
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 50
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 49
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 49
Nuclear imaging for cardiac amyloidosis 49
The spectrum of myocarditis: from pathology to the clinics 49
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 48
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 48
Cardiac amyloidosis: the great pretender 48
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 48
IMPLICAZIONI PRATICHE E NUOVI SCENARI DI PROTEZIONE CARDIOVASCOLARE 48
Relative Left Ventricular Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: Is it Just Amyloid Infiltration? 47
Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy 47
Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy 46
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 46
Redefining the histopathologic profile of acute aortic syndromes: clinical and prognostic implications 45
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 45
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 45
Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis 44
Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels 44
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 43
Interventricular delay optimization: a comparison among three different echocardiographic methods 43
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 42
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 41
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 41
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 40
Primary Cardiac Leiomyoma Causing Right Ventricular Obstruction and Tricuspid Regurgitation 40
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 40
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 40
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access 39
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 39
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 39
Usefulness of electrocardiographic patterns at presentation to predict long-term risk of cardiac death in patients with hypertrophic cardiomyopathy 37
Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome 37
Left ventricular rotational mechanics in patients with coronary artery disease: differences in subendocardial and subepicardial layers 37
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 37
Amyloidosis. Also a heart disease 36
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 36
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy 36
'Corona' versus 'coronary' 36
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis 35
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging 35
Wytyczne ESC dotyczace rozpoznawania i postȩpowania w kardiomiopatii przerostowej w 2014 roku 35
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 35
Transthyretin-related amyloidoses and the heart: a clinical overview 34
Totale 7.080
Categoria #
all - tutte 99.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 569
Totale 100.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.289 69 21 22 79 39 80 70 189 285 209 198 28
2020/20213.368 116 212 182 102 763 335 235 335 235 423 195 235
2021/20221.975 133 87 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/2025203 203 0 0 0 0 0 0 0 0 0 0 0
Totale 10.597